PubMed
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract
Sikiric et al., 2018
Healing & RecoveryResearch OnlyB
KLOW Blend
KLOW Stack · BPC-157 + TB-500 + GHK-Cu + KPV
KLOW is a popular research-community name for a four-peptide pre-blend: BPC-157, TB-500, GHK-Cu, and KPV in one vial (sometimes described as GLOW + KPV). PeptIQ includes KLOW as a searchable blend entry for protocol and inventory logging when the supplier sells a single mixed vial. Published evidence is component-level — not for a fixed FDA-approved combination — and vendor ratios vary. Prefer separate vials when you need independent dose control of each peptide.
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
- Studies cited
- 8
- Research grade
- B
- Experience
- 99
- Activity
- 67
Overall check-ins
Trackers & reports
Overview
About KLOW Blend
KLOW is a popular research-community name for a four-peptide pre-blend: BPC-157, TB-500, GHK-Cu, and KPV in one vial (sometimes described as GLOW + KPV). PeptIQ includes KLOW as a searchable blend entry for protocol and inventory logging when the supplier sells a single mixed vial. Published evidence is component-level — not for a fixed FDA-approved combination — and vendor ratios vary. Prefer separate vials when you need independent dose control of each peptide.
- Category
- Healing & Recovery
- Regulatory status
- Research Only
- Also known as
- KLOW Stack · BPC-157 + TB-500 + GHK-Cu + KPV
- Self-reports
- 43
Community
What 43 users report
43 community reports
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 97% · Mixed 3% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Recovery
197
Most logged side effects
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Injection site irritation
5
Self-reported dose per injection
Median bucket: 2–3 mg · Most common: 2–3 mg
Reports span 0.2–5 mg
0.2–0.4 mg
46
0.4–0.6 mg
6
1–2 mg
43
2–3 mg
65
3–5 mg
37
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
How repeat users are trending
Among repeat reporters, 94% said they felt similar to their last entry, 6% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 73 days · Based on 31 repeat reporters
Research
Cited research (4)
Source
PubMed
Thymosin beta 4 and wound healing: a multifunctional peptide
Goldstein et al., 2010
Review Article
GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes
Pickart et al., 2018
PubMed
Alpha-MSH tripeptide analogs reduce inflammation
Luger et al., 2004
Tools
Explore more
Explore
More ways to learn about KLOW Blend from observational PeptIQ data.
Compare with
Related peptides
Help
Frequently asked
What do PeptIQ users report about KLOW Blend?
This page summarizes 43 anonymized self-reports from PeptIQ users who track KLOW Blend, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
How do side effects relate to overall experience for KLOW Blend?
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
What research is cited for KLOW Blend?
4 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
Is KLOW Blend safe to use?
This wiki does not assess safety or recommend use. KLOW Blend is listed as Research Only. Consult a licensed clinician for personal medical decisions.
What are the purported benefits and uses of KLOW Blend?
This wiki summarizes observational community reports and linked citations for KLOW Blend. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for KLOW Blend for study-level context — not medical advice.
What is the legal status of KLOW Blend?
KLOW Blend is listed in PeptIQ as Research Only. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.
What are the known or theoretical side effects and risks of KLOW Blend?
Safety data quality for KLOW Blend varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.
What is the current state of research on KLOW Blend?
This page links 4 indexed sources for KLOW Blend. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.